NAVAMEDIC A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About NAVAMEDIC A/S
NAVAMEDIC A/S (CVR number: 35483098) is a company from EGEDAL. The company recorded a gross profit of -34.8 kDKK in 2020. The operating profit was -34.8 kDKK, while net earnings were -34.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -2.4 %, which can be considered poor and Return on Equity (ROE) was -2.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 98.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NAVAMEDIC A/S's liquidity measured by quick ratio was 57.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 3 949.34 | 2 272.20 | 24.06 | -15.00 | -34.83 |
EBIT | 350.26 | 241.51 | 23.21 | -15.00 | -34.83 |
Net earnings | 265.95 | 200.51 | 132.94 | -15.00 | -34.83 |
Shareholders equity total | 1 125.95 | 1 326.46 | 1 459.40 | 1 444.40 | 1 409.57 |
Balance sheet total (assets) | 5 023.74 | 4 131.40 | 1 464.29 | 1 470.10 | 1 434.42 |
Net debt | -1 715.39 | 2 277.62 | - 224.66 | - 171.80 | -36.00 |
Profitability | |||||
EBIT-% | |||||
ROA | 7.0 % | 6.2 % | 0.8 % | -1.0 % | -2.4 % |
ROE | 23.6 % | 16.4 % | 9.5 % | -1.0 % | -2.4 % |
ROI | 7.9 % | 6.8 % | 0.9 % | -1.0 % | -2.4 % |
Economic value added (EVA) | 267.90 | 397.26 | -35.07 | -77.05 | -98.78 |
Solvency | |||||
Equity ratio | 22.4 % | 32.1 % | 99.7 % | 98.3 % | 98.3 % |
Gearing | 293.8 % | 194.4 % | |||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.3 | 1.5 | 299.4 | 57.2 | 57.7 |
Current ratio | 1.3 | 1.5 | 299.4 | 57.2 | 57.7 |
Cash and cash equivalents | 5 023.74 | 300.62 | 224.66 | 171.80 | 36.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.